$41.03
At close: May 15, 5:00 PM EST
$41.06
0.030.07%
After Hours: May 13, 7:35 PM EST
Apellis Pharmaceuticals Inc Stock News
APLSNASDAQ
M&A: Apellis Pharmaceuticals (APLS) was acquired by Biogen (BIIB) on Thursday, May 14, 2026 for $5.6B paid in cash
Latest Apellis Pharmaceuticals Stock News | NASDAQ:APLS | Benzinga
Get the latest news on Apellis Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Apellis Pharmaceuticals performance
Categories: All
Friday, May 15, 2026
Thursday, May 14, 2026
Friday, May 08, 2026
Thursday, May 07, 2026
Monday, May 04, 2026
Friday, May 01, 2026
Friday, April 17, 2026
Tuesday, April 07, 2026
Monday, April 06, 2026
Friday, April 03, 2026
Thursday, April 02, 2026
Wednesday, April 01, 2026
- JP Morgan Downgrades Apellis Pharmaceuticals ...PRO
- Barclays Maintains Equal-Weight on Apellis Ph...PRO
- Raymond James Downgrades Apellis Pharmaceutic...PRO
- This PPG Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
- Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
- Citigroup Downgrades Apellis Pharmaceuticals ...PRO
- HC Wainwright & Co. Downgrades Apellis Pharma...PRO
Tuesday, March 31, 2026
- Needham Downgrades Apellis Pharmaceuticals to...PRO
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook
- Biogen Lands Two Fast-Growing Drugs In Blockbuster Apellis Deal
- Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
- Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Apellis Pharmaceuticals share are trading hig...PRO
- Biogen Agrees To Acquire All Outstanding Shar...PRO
